Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5002 Cowhorn Creek Rd
Texarkana, TX 75503Phone+1 903-614-3000Fax+1 903-614-3525
Education & Training
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1987 - 1990- University of Arkansas For Medical Sciences College of MedicineClass of 1987
Certifications & Licensure
AR State Medical License 1987 - 2026
TX State Medical License 1990 - 2025
Clinical Trials
- Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II Start of enrollment: 2003 May 01
- REVEAL III: Risk Evaluation and Education for Alzheimer's Disease Start of enrollment: 2007 Mar 01
- Risk Evaluation and Education for Alzheimer's Disease Start of enrollment: 2000 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsLow frequency of treatable pediatric disease alleles in gnomAD: An opportunity for future genomic screening of newbornsNina B. Gold, Steven M. Harrison, Jared H. Rowe, Jessica Gold, Elissa M. Furutani
HGG Advances. 2022-01-13 - 106 citationsGA4GH: International policies and standards for data sharing across genomic research and healthcareHeidi L. Rehm, Angela Page, Lindsay Smith, Jeremy Adams, Gil Alterovitz
Cell Genomics. 2021-11-10 - 32 citationsReturning actionable genomic results in a research biobank: Analytic validity, clinical implementation, and resource utilization.Carrie L. Blout Zawatsky, Nidhi Shah, Kalotina Machini, Emma Perez, Kurt D. Christensen
American Journal of Human Genetics. 2021-11-08
Press Mentions
Single Blood Test Reveals 10% of Babies at Risk of Genetic IllnessJanuary 9th, 2019
Genetic Screening for Newborns Yields Some Answers, More QuestionsJanuary 4th, 2019
Baby DNA: Boston Researchers Find Childhood Genetic Risks in 9 Percent of NewbornsJanuary 3rd, 2019- Join now to see all
Grant Support
- Integration Of Whole Genome Sequencing Into Clinical MedicineNational Human Genome Research Institute2012
- Risk Evaluation And Education For Alzheimer'S Disease (Reveal Iv)National Human Genome Research Institute2011
- Impact Of Direct To Consumer Genetic TestingNational Human Genome Research Institute2011
- Characterizing And Communicating Genetic Risk For Alzheimer'S DiseaseNational Institute On Aging2010
- Risk Evaluation And Education For Alzheimer'S Disease (Reveal Iv)National Human Genome Research Institute2010
- Impact Of Direct To Consumer Genetic TestingNational Human Genome Research Institute2010
- Characterizing And Communicating Genetic Risk For Alzheimer'S DiseaseNational Institute On Aging2007–2010
- Core--ClinicalNational Institute On Aging2001–2010
- Risk Evaluation And Education For Alzheimer'S DiseaseNational Human Genome Research Institute2003–2009
- Mpc-7869 Measure Of Cognition, Activities Mild Dementia Of The Alzheimer'S TypeNational Center For Research Resources2007
- Study Of Leuprolide Acetate Depot In The Treatment Of AD In MenNational Center For Research Resources2006–2007
- Alzheimer'S Disease Neuroimaging Initiative (ADNI)National Center For Research Resources2006–2007
- High Dose Supplements To Reduce Homocysteine In Alzheimer'S DiseaseNational Center For Research Resources2005–2007
- Genetic Risk Assessment And Counseling For Alzheimer'S Disease (REVEAL)National Center For Research Resources2005–2007
- Assessment Measures For Primary Prevention Trials In Alzheimers DiseaseNational Center For Research Resources2005–2007
- Alzheimer'S Disease Anti-Inflammatory Prevention Trial (ADAPT)National Center For Research Resources2005–2007
- Simvastatin To Slow The Progression Of Alzheimer'S DiseaseNational Center For Research Resources2004–2007
- Aging And Alzheimer'S Disease Biosample RepositoryNational Center For Research Resources2004–2007
- Characterizing Communicating Genetic Risk Alzheimer'SNational Institute On Aging2006
- Pilot Testing Of Serum And Beta-Amyloid LevelsNational Center For Research Resources2004
- High Dose Supplements To Reduce Homocysteine In ADNational Center For Research Resources2004
- Genetic Risk Assessment And Counseling For ADNational Center For Research Resources2004
- Assessment Measures For Primary Prevention Trials In ADNational Center For Research Resources2004
- Alzheimer'S Disease Anti-Inflammatory Prevention TrialNational Center For Research Resources2004
- Genetic Risk Assessment For Alzheimer'S DiseaseNational Human Genome Research Institute1999–2003
- Behavior Management Interventions In Alzheimers DiseaseNational Institute On Aging1994
- Behavior Management Interventions In Alzheimer'S DiseaseNational Institute On Aging1992–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
